Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/− Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic Targets.
Saved in:
| Title: | Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/− Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic Targets. |
|---|---|
| Authors: | Gide, Tuba N.1,2,3 (AUTHOR) tuba.gide@sydney.edu.au, Pires da Silva, Inês1,2,3 (AUTHOR) Ines.Silva@melanoma.org.au, Quek, Camelia1,2,3 (AUTHOR) camelia.quek@melanoma.org.au, Ferguson, Peter M.1,3,4,5 (AUTHOR) Peter.Ferguson@melanoma.org.au, Batten, Marcel1,2,3 (AUTHOR) marcel.batten@sydney.edu.au, Shang, Ping1,2 (AUTHOR) ping.shang@melanoma.org.au, Ahmed, Tasnia1 (AUTHOR) tasnia.ahmed@melanoma.org.au, Menzies, Alexander M.1,2,3,6,7 (AUTHOR) alexander.menzies@sydney.edu.au, Carlino, Matteo S.1,3,8 (AUTHOR) matteo.carlino@sydney.edu.au, Saw, Robyn P. M.1,3,5,7 (AUTHOR) robyn.saw@melanoma.org.au, Thompson, John F.1,3,5,7 (AUTHOR) John.Thompson@melanoma.org.au, Scolyer, Richard A.1,2,3,4,5 (AUTHOR) Richard.Scolyer@health.nsw.gov.au, Long, Georgina V.1,2,3,6,7 (AUTHOR) georgina.long@sydney.edu.au, Wilmott, James S.1,2,3 (AUTHOR) james.wilmott@sydney.edu.au |
| Source: | Cancers. Jul2021, Vol. 13 Issue 13, p3186-3186. 1p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers13133186 |
